NEPH
Nephros, Inc. (NEPH) SWOT Analysis Analysis (2026)
No material changes this month.
Strengths
ROIC of 12.7% indicates NEPH is converting capital into returns better than many small-cap peers, supporting a modest structural edge in capital allocation efficiency.
A current ratio of 4.1 and quick ratio of 2.7 suggest stronger near-term liquidity than leveraged peers, reducing refinancing pressure and preserving operating flexibility.
Net debt to EBITDA of -2.1 implies net cash rather than net leverage, which is materially stronger than indebted peers and lowers balance-sheet risk.
Low debt-to-equity of 0.07 indicates conservative leverage versus peers, helping NEPH retain financial optionality when competitors face tighter credit conditions.
Weaknesses
Cash conversion cycle of 186.7 days is long versus peers, tying up working capital and limiting the speed at which accounting profits become usable cash.
The absence of disclosed margin metrics weakens visibility into operating efficiency relative to peers, making it harder to evidence a durable cost or pricing advantage.
Limited growth disclosure on revenue, EPS, and FCF CAGR prevents confirmation that NEPH is outgrowing peers, which constrains confidence in its competitive trajectory.
The balance sheet is conservative, but that strength can also reflect a smaller scale profile than stronger peers, which may limit bargaining power and operating leverage.
Opportunities
If NEPH shortens its cash conversion cycle, it could release working capital faster than peers and improve cash generation without requiring revenue acceleration.
With net cash and low leverage, NEPH has more capacity than indebted peers to fund selective expansion, acquisitions, or internal investment if returns remain attractive.
Strong liquidity gives NEPH room to absorb temporary demand volatility better than peers, which can support continuity in customer service and supplier terms.
Any future disclosure of sustained revenue or FCF growth could re-rate NEPH versus peers by confirming that current balance-sheet strength is paired with scalable demand.
Threats
A prolonged 186.7-day cash conversion cycle leaves NEPH more exposed than peers to inventory, receivables, or reimbursement slippage that can pressure liquidity.
If peers improve working-capital efficiency faster, NEPH’s current liquidity advantage could narrow even while its capital remains conservatively structured.
The lack of margin disclosure raises the risk that peers with clearer operating leverage may sustain superior profitability, limiting NEPH’s relative positioning.
Without evidence of durable growth metrics, NEPH may be vulnerable to peers that compound faster and gradually outpace its capital efficiency advantage.
Overall Score
NEPH’s peer positioning is supported by a strong balance sheet and acceptable capital returns, but long working-capital intensity and limited operating disclosure keep the overall profile moderate.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Nephros, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
